Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration-Reference-Cited by-同舟云学术

Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration

Published:2006-05-28 Issue:6 Volume:24 Page:687-696
ISSN:1087-0156
Container-title:Nature Biotechnology
language:en
Short-container-title:Nat Biotechnol

Author:

Montini Eugenio,Cesana Daniela,Schmidt Manfred,Sanvito Francesca,Ponzoni Maurilio,Bartholomae Cynthia,Sergi Lucia Sergi,Benedicenti Fabrizio,Ambrosi Alessandro,Di Serio Clelia,Doglioni Claudio,von Kalle Christof,Naldini Luigi

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

http://www.nature.com/articles/nbt1216.pdf

Reference49 articles.

1. Schroder, A. et al. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110, 521–529 (2002).

2. Wu, X., Li, Y., Crise, B. & Burgess, S.M. Transcription start regions in the human genome are favored targets for MLV integration. Science 300, 1749–1751 (2003).

3. Mitchell, R.S. et al. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2, E234 (2004).

4. Hematti, P. et al. Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells. PLoS Biol. 2, e423 (2004).

5. De Palma, M. et al. Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells. Blood 105, 2307–2315 (2005).

Cited by 595 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving the Assessment of Risk Factors Relevant to Potential Carcinogenicity of Gene Therapies: A Consensus Article;Human Gene Therapy;2024-08-01

2. Novel Gene Therapy Approaches for Targeting Neurodegenerative Disorders: Focusing on Delivering Neurotrophic Genes;Molecular Neurobiology;2024-06-10

3. The Fate(s) of CAR T-Cell Therapy: Navigating the Risks of CAR+ T-Cell Malignancy;Blood Cancer Discovery;2024-06-06

4. Designing molecules: directing stem cell differentiation;Frontiers in Bioengineering and Biotechnology;2024-05-10

5. AAV vectors trigger DNA damage responses and STING-dependent inflammation in human CNS cells;2024-04-10